Poly(ethylene glycol)-grafted polyethylenimine modified with G250 monoclonal antibody for tumor gene therapy

Human Gene Therapy

Volumn 21, Issue 2, 2010, Pages 191-198

  Duan, Yajun ^a   Yang, Cuihong ^a   Zhang, Zhenfang ^a   Liu, Jianfeng ^a,b   Zheng, Junnian ^c   Kong, Deling ^a  

^a NANKAI UNIVERSITY   (China)

^b INSTITUTE OF RADIATION MEDICINE   (China)

^c XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MACROGOL; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY G250; POLYETHYLENEIMINE; POLYMER; RNA; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER GENE THERAPY; CELL STRAIN 3T3; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; LIGHT SCATTERING; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOCOMPATIBLE MATERIALS; CELL LINE, TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HELA CELLS; HEP G2 CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS; NIH 3T3 CELLS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; TRANSFECTION;

EID: 77249109466     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.010     Document Type: Article

References (20)

1. Abdallah, B., Hassan, A., Benoist, C., Goula, D., Behr, J.P., and Demeneix, B.A. (1996). A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Poly-ethylenimine. Hum. Gene Ther. 7, 1947-1954.
2. Blume, G., Cevc, G., Crommelin, M.D., Bakker-Woudenberg, I.A., Kluft, C., and Storm, G. (1993). Specific targeting with poly(ethylene glycol)-modified liposomes: Coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim. Biophys. Acta 1149, 180-184.
3. Boussif, O., Lezoualc'h, F., Zanta, M.A., Mergny, M.D., Scherman, D., Demeneix, B., and Behr, J.P. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. U.S.A. 92, 7297-7301.
4. Dreborg, S., and Akerblom, E.B. (1990). Immunotherapy with monomethoxypolyethylene glycol modified allergens. Crit. Rev. Ther. Drug Carrier Syst. 6, 315-365.
5. Duan, Y., Zheng, J., Han, S., Wu, Y., Wang, Y., Li, D., Kong, D., and Yu, Y. (2008). A tumor targeted gene vector modified with G250 monoclonal antibody for gene therapy. J. Control. Release 127, 173-179.
6. Erbacher, P., Bettinger, T., Belguise-Valladier, P., Zou, S., Coll, J.L., Behr, J.P., and Remy, J.S. (1999). Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J. Gene Med. 1, 210-222.
7. Germershaus, O., Merdan, T., Bakowsky, U., Behe, M., and Kissel, T. (2006). Trastuzumab-polyethylenimine-polyethylene glycol conjugates for targeting Her2-expressing tumors. Bio-conjugate Chem. 17, 1190-1199.
8. Goula, D., Benoist, C., Mantero, S., Merlo, G., Levi, G., and Demeneix, B.A. (1998). Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther. 5, 1291-1295.
9. Kunath, K., von Harpe, A., Petersen, H., Fischer, D., Voigt, K., Kissel, T., and Bickel, U. (2002). The structure of PEG-modified poly(ethylene imines) influences biodistribution and pharma-cokinetics of their complexes with NF-kB decoy in mice. Pharm. Res. 19, 810-817.
10. Manthorpe, M., Cornefert-Jensen, F., Hartikka, J., Felgner, J., Rundell, A., Margalith, M., and Dwarki,V.(1993). Gene therapy by intramuscular injection of plasmid DNA: Studies on firefly luciferase gene expression in mice. Hum. Gene Ther. 4, 419-431.
11. Maruyama, K., Takahashi, N., Tagawa, T., Nagaike, K., and Iwatsuru, M. (1997). Immunoliposomes bearing polyethy-leneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo. FEBS Lett. 413, 177-180.
12. Merdan, T., Kopecek, J., and Kissel, T. (2002). Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv. Drug Deliv. Rev. 54, 715-758.
13. Miyatake, S.I., Tani, S., Feigenbaum, F., Sundaresan, P., Toda, H., Narumi, O., Kikuchi, H., Hashimoto, N., Hangai, M., Martuza, R.L., and Rabkin, S.D. (1999). Hepatoma-specific antitumor activity of an albumin enhancer=promoter regulated herpes simplex virus in vivo. Gene Ther. 6, 564-572.
14. Nguyen, H.K., Lemieux, P., Vinogradov, S.V., Gebhart, C.L., Guérin, N., Paradis, G., Bronich, T.K., Alakhov, V.Y., and Ka-banov, A.V. (2000). Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther. 7, 126-138.
15. Petersen, H., Fechner, P.M., Fischer, D., and Kissel, T. (2002a). Synthesis, characterization, and biocompatibility of poly-ethylenimine-graft- poly(ethylene glycol) block copolymers. Macromolecules 35, 6867-6874.
16. Petersen, H., Fechner, P.M., Martin, A.L., Kunath, K., Stolnik, S., Roberts, C.J., Fischer, D., Davies, M.C., and Kissel, T. (2002b). Polyethylenimine-graft-poly(ethylene glycol) copolymers: Influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjugate Chem. 13, 845-854.
17. Sung, S.J., Min, S.H., Cho, K.Y., Lee, S., Min, Y.J., Yeom, Y.I., and Park, J.K. (2003). Effect of polyethylene glycol on gene delivery of polyethylenimine. Biol. Pharm. Bull. 26, 492-500.
18. Thorpe, P.E., Blakey, D.C., Brown, A.N., Knowles, P.P., Knyba, R.E., Wallace, P.M., Watson, G.J., and Wawrzynczak, E.J. (1987). Comparison of two anti-Thy 1.1-abrin A-chain im-munotoxins prepared with different cross-linking agents: Antitumor effects, in vivo fate, and tumor cell mutants. J. Natl. Cancer Inst. 79, 1101-1112.
19. Torchilin, V.P., Klibanov, A.L., Huang, L., O'Donnell, S., Nossiff, N.D., and Khaw, B.A. (1992). Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium. FASEB J. 6, 2716-2719.
20. Uemura, H., Nakagawa, Y., Yoshida, K., Saga, S., Yoshikawa, K., Hirao, Y., and Oosterwijk, E. (1999). MN=CA IX=G250 as a potential target for immunotherapy of renal cell carcinomas. Br. J. Cancer 81, 741-746.